Identifying NDUFB2 as a prognostic biomarker for glioblastoma through an exploratory analysis of an anesthesia-related gene signature
Jingwen Wei, Liyun Zou, Qing Liu, Yubo Xie · 2025
Read Identifying NDUFB2 as a prognostic biomarker for glioblastoma through an exploratory analysis of an anesthesia-related gene signature by Jingwen Wei, Liyun Zou, Qing Liu, Yubo Xie (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12777021.txt.
Description
A peer-reviewed research article from Europe PMC (2025). BackgroundGlioblastoma (GBM) is the most aggressive primary brain tumor with poor prognosis despite multimodal therapy. Understanding the molecular and genetic characteristics of GBM and the influence of anesthesia drugs on tumor behavior is crucial for developing new therapeutic strategies.MethodsWe analyzed RNA-seq data from The Cancer Genome Atlas (TCGA)-GBM cohort and a Gene Expression Omnibus (GEO) dataset (GSE179004) of GBM samples treated with propofol and sevoflurane. Differential expression analysis identified anesthesia-related genes (ARGs), and their prognostic relevance was assessed using Cox regression.
Catalog record
| CREATOR | Jingwen Wei, Liyun Zou, Qing Liu, Yubo Xie |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |